HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 98.3 EUR 6.2% Market Closed

Market Cap: €10.3B

C	Corcept Therapeutics Inc F:HTD	US
J	JPMorgan Chase & Co XHAM:CMC	US
N	Nextera Energy Inc XMUN:FP3	US
N	National Grid PLC F:NNGD	UK
C	Caterpillar Inc SIX:CAT	US
D	Deutsche Boerse AG XMUN:DB1	DE
W	Wells Fargo & Co F:NWT	US
K	Kingspan Group PLC F:KRX	IE
T	TTM Technologies Inc XMUN:TT1	US

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Low Operating Margin

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

23% > 1%

Low Net Margin

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

22% > 7%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

23%

Declining Free Cash Flow Margin

31% > 13%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

31%

Declining ROIC

63% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.